DECIMA

  • Research type

    Research Study

  • Full title

    Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma

  • IRAS ID

    274302

  • Contact name

    Vicky Goh

  • Contact email

    vicky.goh@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    4 years, 11 months, 1 days

  • Research summary

    Up to 30% of patients with newly diagnosed/suspected myeloma cannot undergo or do not tolerate whole body MRI (WB-MRI). A number of factors may be contributory. First, WB-MRI protocols can take in excess of 1 hour. Patients must remain still within a narrow bore scanner with multiple MRI coils that can be claustrophobic. Second, there is significant acoustic noise that can be heard despite the use of ear protection. Third, 80% of patients will experience bone pain or fracture at some point during their illness, affecting their comfort within the scanner. Fourth, patients also have higher anxiety. One review reported up to 30% of patients experienced considerable apprehension and up to 10% severe psychological distress when undergoing MRI. Finally, myeloma is predominantly an illness of the elderly and co-morbid conditions decrease patients' ability to tolerate a long scan. When WB-MRI cannot be performed, NICE recommend whole-body computed tomography (WB-CT), which we know offers decreased diagnostic performance in terms of marrow assessment and focal lesion detection.

    We believe that using a novel CT technique - dual-energy CT (DECT) - may offer better diagnostic performance over standard WB-CT in myeloma patients. What we seek to do in this study is to evaluate the sensitivity and specificity of DECT in a cohort of untreated patients; and compare the performance of DECT to simulated standard CT (data simulated from the DECT) and also to WB-MRI (reference standard alongside bone marrow biopsy results. We will assess both subjective visual analysis of DECT images as well as CT quantitative values for the bone marrow. Secondary objectives include assessment of patient experience across both imaging tests and assessment of intra & inter observer variability in subjective visual analysis.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    22/LO/0082

  • Date of REC Opinion

    9 Feb 2022

  • REC opinion

    Favourable Opinion